Coding conundrum – billing options if vials must be remixed
The Advocacy Council regularly receives queries from members on how to correctly code specific scenarios. Here is a recent request.
Reimbursement challenges for allergy/immunotherapy services remain a problem
ACAAI’s Advocacy Council has made addressing these issues a top priority through our Payer Education Campaign and related initiatives
2026 HIPAA updates
This update provides members with a high-level overview with specific considerations for allergy and immunology practices.
Advocacy Council fights for you on Capitol Hill
Members of the ACAAI Advocacy Council were on Capitol Hill fighting for issues important to allergy practices last week.
New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
We’re defending and empowering allergists
The ACAAI is the only allergy organization backed by Washington-based experts and consultants whose primary focus is allergy/immunology.
ACAAI applauds the latest expansion of GME slots
CMS announced the distribution of 400 new federally funded graduate medical education residency positions to hospitals across the country.
Medicare payment policies expire again
A brief lapse in funding is unlikely to trigger a full government shutdown of the agencies funded by the minibus
Claim denials for CPT code 95165 are growing
These requirements can significantly impact allergy practices that rely on preparing customized, multi-dose vials in advance.
… results in Advocacy Insider.
